Search - tctmd.com

Displaying 621 - 640 of 3143

Sort: Relevancy | Date

Video

» Interview

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

May 4, 2022

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Video

» Interview

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

May 4, 2022

Video

» On Record

Aortic Valve Replacement: Can Choices Be Conveyed to Patients?

April 29, 2022

Video

» Topical Discussion

TCTMD's Quick Takes: Jasmine Madsen

April 20, 2022

Video

» On Record

Heart Failure Highlights from ACC 2022

April 13, 2022

Video

» Interview

ACC 2022: PACMAN AMI - Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

April 12, 2022

Video

» Interview

ACC 2022: TRANSLATE-TIMI 70: Effect Of Vupanorsen On Non-high-density Lipoprotein Cholesterol Levels In Statin-treated Patients With Elevated Cholesterol

April 12, 2022

Video

» Interview

ACC 2022: The POISE-3 Trial: Efficacy and Safety of Tranexamic Acid in Patients Undergoing Noncardiac Surgery

April 12, 2022

Video

» Fellows Forum

Seeking Quality Mentorship as a Trainee: Advice and Red Flags

April 11, 2022

Video

» Topical Discussion

EBC Possible Risks Associated with Bifurcation

April 7, 2022

Video

» Interview

Beyond the Data: FLAVOUR

April 6, 2022

Video

» Interview

Beyond the Data: ADAPT-TAVR

April 6, 2022

Video

» Conference Wrap-Up

ACC 2022 Day 2 Wrap-Up

April 3, 2022

Video

» Interview

Beyond the Data: Perspectives from the Ukrainian Border

April 3, 2022

Video

» Interview

Beyond the Data: PACMAN-AMI

April 3, 2022

Video

» Interview

Beyond the Data: Heart Failure Updates and Key Takeaways

April 3, 2022

Video

» Interview

Beyond the Data: Women’s CV Health Updates

April 3, 2022

Video

» Interview

Beyond the Data: ACS/PCI Updates

April 3, 2022

Video

» Interview

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

April 3, 2022

Advertisement

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

Aortic Valve Replacement: Can Choices Be Conveyed to Patients?

TCTMD's Quick Takes: Jasmine Madsen

Heart Failure Highlights from ACC 2022

ACC 2022: PACMAN AMI - Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

ACC 2022: TRANSLATE-TIMI 70: Effect Of Vupanorsen On Non-high-density Lipoprotein Cholesterol Levels In Statin-treated Patients With Elevated Cholesterol

ACC 2022: The POISE-3 Trial: Efficacy and Safety of Tranexamic Acid in Patients Undergoing Noncardiac Surgery

Seeking Quality Mentorship as a Trainee: Advice and Red Flags

EBC Possible Risks Associated with Bifurcation

Beyond the Data: FLAVOUR

Beyond the Data: ADAPT-TAVR

ACC 2022 Day 2 Wrap-Up

Beyond the Data: Perspectives from the Ukrainian Border

Beyond the Data: PACMAN-AMI

Beyond the Data: Heart Failure Updates and Key Takeaways

Beyond the Data: Women’s CV Health Updates

Beyond the Data: ACS/PCI Updates

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content